# HB 1023: Relating to modification of certain prescription drug benefits and coverage offered by certain health benefit plans.

90th Legislature (90R) · House · Status: Filed

Record current as of: the Legislative Council last updated this bill's record 11/13/2026 2:00:05 AM; this site copied it 2026-11-22T04:18:46.160732Z.

How to read this page: **Official record** is copied unchanged from the Texas Legislative Council's bill files, the data behind Texas Legislature Online. **Computed by this site** is worked out by fixed rules from that record. **AI analysis (Luna)** is written by an AI model that read the bill text; it can be wrong, so check it against the bill text.

## Official record

Source: Texas Legislative Council bill files (ftp.legis.state.tx.us), copied unchanged.

- Filed: 2026-11-10
- Most recent action: 2026-11-10 · House: Filed
- Official subjects (Legislative Council index): Insurance--Health & Accident; MEDICINE & PRESCRIPTION DRUGS
- Companion bills: none listed in the source data

### Caption

Relating to modification of certain prescription drug benefits and coverage offered by certain health benefit plans.

### Bill text

The official wording of each version, copied from the Texas Legislative Council's bill text files and converted to Markdown with the wording unchanged. Language the bill adds is marked <ins>like this</ins>; language it removes is in [<del>brackets</del>]. To check a copy, fetch the official file and compare its SHA-256 with the one listed; the copy's own SHA-256 confirms you received it unaltered.

- Introduced: https://billatlas.org/live/text/HB1023/I.md
  - Official file: ftp://ftp.legis.state.tx.us/bills/90R/billtext/HTML/house_bills/HB01000_HB01099/HB01023I.HTM, last modified 2026-11-10 15:32:17 UTC, SHA-256 8b73a5df9f5421bf1ef74e776dd2b9ee7944cb4f4cd91d10a86cbb1db1485e7e
  - This copy: made 2026-11-13T08:27:58.309882Z, SHA-256 of the Markdown 44702e1ee0f67701de838da92fb8ec9497cae9ddad2dac70aec6727d21d17aa0

#### Text of the latest version (Introduced)

````markdown
# HB 1023 - Introduced

90R4360 SCR-F

By: Jones of Dallas H.B. No. 1023

A BILL TO BE ENTITLED

AN ACT

relating to modification of certain prescription drug benefits and coverage offered by certain health benefit plans.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

### SECTION 1.

Section 1369.053, Insurance Code, is amended to read as follows:

Sec. 1369.053. EXCEPTION. This subchapter does not apply to:

(1) a health benefit plan that provides coverage:

(A) only for a specified disease or for another single benefit;

(B) only for accidental death or dismemberment;

(C) for wages or payments in lieu of wages for a period during which an employee is absent from work because of sickness or injury;

(D) as a supplement to a liability insurance policy;

(E) for credit insurance;

(F) only for dental or vision care;

(G) only for hospital expenses; or

(H) only for indemnity for hospital confinement;

(2) a Medicare supplemental policy as defined by Section 1882(g)(1), Social Security Act (42 U.S.C. Section 1395ss), as amended;

(3) a workers' compensation insurance policy;

(4) medical payment insurance coverage provided under a motor vehicle insurance policy;

(5) a long-term care insurance policy, including a nursing home fixed indemnity policy, unless the commissioner determines that the policy provides benefit coverage so comprehensive that the policy is a health benefit plan as described by Section 1369.052;

(6) the child health plan program under Chapter 62, Health and Safety Code, or the health benefits plan for children under Chapter 63, Health and Safety Code; \[<del>or</del>\]

(7) a Medicaid managed care program operated under Chapter 540 or 540A, Government Code, as applicable, or a Medicaid program operated under Chapter 32, Human Resources Code<ins>; or</ins>

<ins>(8) a self-funded health benefit plan as defined by the Employee Retirement Income Security Act of 1974 (29 U.S.C. Section 1001 et seq.)</ins>.

### SECTION 2.

Section 1369.0541, Insurance Code, is amended by amending Subsections (a) and (b) and adding Subsections (a-1) and (b-1) to read as follows:

(a) <ins>Except as provided by Section 1369.055(a-1) and Subsection (b-1) of this section, a</ins> \[<del>A</del>\] health benefit plan issuer may modify drug coverage provided under a health benefit plan if:

(1) the modification occurs at the time of coverage renewal;

(2) the modification is effective uniformly among all group health benefit plan sponsors covered by identical or substantially identical health benefit plans or all individuals covered by identical or substantially identical individual health benefit plans, as applicable; and

(3) not later than the 60th day before the date the modification is effective, the issuer provides written notice of the modification to the commissioner, each affected group health benefit plan sponsor, each affected enrollee in an affected group health benefit plan, and each affected individual health benefit plan holder.

<ins>(a-1) The notice described by Subsection (a)(3) must include a statement:</ins>

<ins>(1) indicating that the health benefit plan issuer is modifying drug coverage provided under the health benefit plan;</ins>

<ins>(2) explaining the type of modification; and</ins>

<ins>(3) indicating that, on renewal of the health benefit plan, the health benefit plan issuer may not modify an enrollee's contracted benefit level for any prescription drug that was approved or covered under the plan in the immediately preceding plan year as provided by Section 1369.055(a-1).</ins>

(b) Modifications affecting drug coverage that require notice under Subsection (a) include:

(1) removing a drug from a formulary;

(2) adding a requirement that an enrollee receive prior authorization for a drug;

(3) imposing or altering a quantity limit for a drug;

(4) imposing a step-therapy restriction for a drug; \[<del>and</del>\]

(5) moving a drug to a higher cost-sharing tier<ins>;</ins>

<ins>(6) increasing a coinsurance, copayment, deductible, or other out-of-pocket expense that an enrollee must pay for a drug; and</ins>

<ins>(7) reducing the maximum drug coverage amount</ins> \[<del>unless a generic drug alternative to the drug is available</del>\].

<ins>(b-1) Modifications affecting drug coverage that are more favorable to enrollees may be made at any time and do not require notice under Subsection (a), including:</ins>

<ins>(1) the addition of a drug to a formulary;</ins>

<ins>(2) the reduction of a coinsurance, copayment, deductible, or other out-of-pocket expense that an enrollee must pay for a drug; and</ins>

<ins>(3) the removal of a utilization review requirement.</ins>

### SECTION 3.

Section 1369.055, Insurance Code, is amended by adding Subsections (a-1), (a-2), and (c) to read as follows:

<ins>(a-1) On renewal of a health benefit plan, the plan issuer may not modify an enrollee's contracted benefit level for any prescription drug that was approved or covered under the plan in the immediately preceding plan year and prescribed during that year for a medical condition or mental illness of the enrollee if:</ins>

<ins>(1) the enrollee was covered by the health benefit plan on the date immediately preceding the renewal date;</ins>

<ins>(2) a physician or other prescribing provider prescribes the drug for the medical condition or mental illness; and</ins>

<ins>(3) the physician or other prescribing provider in consultation with the enrollee determines that the drug is the most appropriate course of treatment.</ins>

<ins>(a-2) Modifications prohibited under Subsection (a-1) include:</ins>

<ins>(1) removing a drug from a formulary;</ins>

<ins>(2) adding a requirement that an enrollee receive prior authorization for a drug;</ins>

<ins>(3) imposing or altering a quantity limit for a drug;</ins>

<ins>(4) imposing a step-therapy restriction for a drug;</ins>

<ins>(5) moving a drug to a higher cost-sharing tier;</ins>

<ins>(6) increasing a coinsurance, copayment, deductible, or other out-of-pocket expense that an enrollee must pay for a drug; and</ins>

<ins>(7) reducing the maximum drug coverage amount.</ins>

<ins>(c) Subsections (a-1) and (a-2) do not:</ins>

<ins>(1) prohibit a health benefit plan issuer from requiring, by contract, written policy or procedure, or other agreement or course of conduct, a pharmacist to provide a substitution for a prescription drug in accordance with Subchapter A, Chapter 562, Occupations Code, under which the pharmacist may substitute an interchangeable biologic product or therapeutically equivalent generic product as determined by the United States Food and Drug Administration;</ins>

<ins>(2) prohibit a physician or other prescribing provider from prescribing another medication;</ins>

<ins>(3) prohibit the health benefit plan issuer from adding a new drug to a formulary;</ins>

<ins>(4) require a health benefit plan to provide coverage to an enrollee under circumstances not described by Subsection (a-1); or</ins>

<ins>(5) prohibit a health benefit plan issuer from removing a drug from its formulary or denying an enrollee coverage for the drug if:</ins>

<ins>(A) the United States Food and Drug Administration has issued a statement about the drug that calls into question the clinical safety of the drug;</ins>

<ins>(B) the drug manufacturer has notified the United States Food and Drug Administration of a manufacturing discontinuance or potential discontinuance of the drug as required by Section 506C, Federal Food, Drug, and Cosmetic Act (21 U.S.C. Section 356c); or</ins>

<ins>(C) the drug manufacturer has removed the drug from the market.</ins>

### SECTION 4.

The changes in law made by this Act apply only to a health benefit plan that is delivered, issued for delivery, or renewed on or after January 1, 2028. A health benefit plan delivered, issued for delivery, or renewed before January 1, 2028, is governed by the law as it existed immediately before the effective date of this Act, and that law is continued in effect for that purpose.

### SECTION 5.

This Act takes effect September 1, 2027.
````

### Current law this bill changes

Each section as it stands now, from this site's copy of the Texas Legislative Council's statute files (wording unchanged); the official page is the authority. Sections are matched automatically from the bill text and can be missed, for example when a bill changes a whole chapter at once.

- Insurance Code §1369.053 (amended): Sec. 1369.053. EXCEPTION.
  - This copy (whole chapter): https://billatlas.org/live/law/IN/1369.md, copied 2026-11-21T02:14:24.675852+00:00, SHA-256 of the Markdown f8785bcfb6622020cf6b6c725e13561e4f665ce024528ad37c8c09f7087953ea
  - Official: https://statutes.capitol.texas.gov/Docs/IN/htm/IN.1369.htm

````markdown
Sec. 1369.053. EXCEPTION. This subchapter does not apply to:

(1) a health benefit plan that provides coverage:

(A) only for a specified disease or for another single benefit;

(B) only for accidental death or dismemberment;

(C) for wages or payments in lieu of wages for a period during which an employee is absent from work because of sickness or injury;

(D) as a supplement to a liability insurance policy;

(E) for credit insurance;

(F) only for dental or vision care;

(G) only for hospital expenses; or

(H) only for indemnity for hospital confinement;

(2) a Medicare supplemental policy as defined by Section 1882(g)(1), Social Security Act (42 U.S.C. Section 1395ss), as amended;

(3) a workers' compensation insurance policy;

(4) medical payment insurance coverage provided under a motor vehicle insurance policy;

(5) a long-term care insurance policy, including a nursing home fixed indemnity policy, unless the commissioner determines that the policy provides benefit coverage so comprehensive that the policy is a health benefit plan as described by Section 1369.052;

(6) the child health plan program under Chapter 62, Health and Safety Code, or the health benefits plan for children under Chapter 63, Health and Safety Code; or

(7) a Medicaid managed care program operated under Chapter 540 or 540A, Government Code, as applicable, or a Medicaid program operated under Chapter 32, Human Resources Code.

Added by Acts 2003, 78th Leg., ch. 1274, Sec. 3, eff. April 1, 2005.

Amended by:

Acts 2011, 82nd Leg., R.S., Ch. 501 (H.B. 1405), Sec. 3, eff. September 1, 2011.

Acts 2023, 88th Leg., R.S., Ch. 769 (H.B. 4611), Sec. 2.125, eff. April 1, 2025.
````

- Insurance Code §1369.055 (amended): Sec. 1369.055. CONTINUATION OF COVERAGE REQUIRED; OTHER DRUGS NOT PRECLUDED.
  - This copy (whole chapter): https://billatlas.org/live/law/IN/1369.md, copied 2026-11-21T02:14:24.675852+00:00, SHA-256 of the Markdown f8785bcfb6622020cf6b6c725e13561e4f665ce024528ad37c8c09f7087953ea
  - Official: https://statutes.capitol.texas.gov/Docs/IN/htm/IN.1369.htm

````markdown
Sec. 1369.055. CONTINUATION OF COVERAGE REQUIRED; OTHER DRUGS NOT PRECLUDED. (a) An issuer of a health benefit plan that covers prescription drugs shall offer to each enrollee at the contracted benefit level and until the enrollee's plan renewal date any prescription drug that was approved or covered under the plan for a medical condition or mental illness, regardless of whether the drug has been removed from the health benefit plan's drug formulary before the plan renewal date.

(b) This section does not prohibit a physician or other health professional who is authorized to prescribe a drug from prescribing a drug that is an alternative to a drug for which continuation of coverage is required under Subsection (a) if the alternative drug is:

(1) covered under the health benefit plan; and

(2) medically appropriate for the enrollee.

Added by Acts 2003, 78th Leg., ch. 1274, Sec. 3, eff. April 1, 2005.

Amended by:

Acts 2011, 82nd Leg., R.S., Ch. 501 (H.B. 1405), Sec. 6, eff. September 1, 2011.
````

- Insurance Code §1369.0541 (amended): Sec. 1369.0541. MODIFICATION OF DRUG COVERAGE UNDER PLAN.
  - This copy (whole chapter): https://billatlas.org/live/law/IN/1369.md, copied 2026-11-21T02:14:24.675852+00:00, SHA-256 of the Markdown f8785bcfb6622020cf6b6c725e13561e4f665ce024528ad37c8c09f7087953ea
  - Official: https://statutes.capitol.texas.gov/Docs/IN/htm/IN.1369.htm

````markdown
Sec. 1369.0541. MODIFICATION OF DRUG COVERAGE UNDER PLAN. (a) A health benefit plan issuer may modify drug coverage provided under a health benefit plan if:

(1) the modification occurs at the time of coverage renewal;

(2) the modification is effective uniformly among all group health benefit plan sponsors covered by identical or substantially identical health benefit plans or all individuals covered by identical or substantially identical individual health benefit plans, as applicable; and

(3) not later than the 60th day before the date the modification is effective, the issuer provides written notice of the modification to the commissioner, each affected group health benefit plan sponsor, each affected enrollee in an affected group health benefit plan, and each affected individual health benefit plan holder.

(b) Modifications affecting drug coverage that require notice under Subsection (a) include:

(1) removing a drug from a formulary;

(2) adding a requirement that an enrollee receive prior authorization for a drug;

(3) imposing or altering a quantity limit for a drug;

(4) imposing a step-therapy restriction for a drug; and

(5) moving a drug to a higher cost-sharing tier unless a generic drug alternative to the drug is available.

(c) A health benefit plan issuer may elect to offer an enrollee in the plan the option of receiving notifications required by this section by e-mail.

Added by Acts 2011, 82nd Leg., R.S., Ch. 501 (H.B. 1405), Sec. 5, eff. September 1, 2011.
````


### Authors and sponsors

Authors and coauthors serve in the originating chamber; sponsors and cosponsors in the other chamber. Authorship does not indicate a vote or caucus position.

#### Authors

- Venton Jones (Democratic · HD 100 · 4 years served · since 2023) · [bills](https://agent.billatlas.org/authors/house-jones-venton.md)

_No coauthors, sponsors or cosponsors listed: no bill in this snapshot lists any yet, so this reflects the stage of the source data, not this bill._

### Recorded actions

1. 2026-11-10: Filed

## Computed by this site

Worked out by fixed rules from the official record above; not a statement by the Legislature.

- Status: Filed
- Most recent action type: Filed
- Hearing status: No hearing yet. No committee referral or hearing has been verified. A likelihood estimate would be premature.
- Authorship: Democratic author. Authors: 1 Democratic
- Author prominence: Mid-tenure author. 4 years in the House

## AI analysis (Luna)

Written by Luna, an AI model that reads the full bill text. It can be wrong; the bill text above is the authority. Tags marked caption-rules come from keyword rules applied to the caption, not from the AI.

### Summary

Reviewed 2026-11-14T04:11:03Z · introduced text. Fields from the full text: topics, agencies, impacts, constituencies, locations; other fields use caption inference.

The bill would exempt self-funded ERISA health benefit plans from this subchapter and change notice requirements for prescription drug coverage modifications. At renewal, issuers generally could not reduce a qualifying enrollee’s contracted benefit level for a drug covered in the prior plan year when the bill’s prescribing and treatment conditions are met, subject to specified exceptions. The changes would apply to plans delivered, issued, or renewed on or after January 1, 2028.

### Topics

- Healthcare
- Business regulation

### Potentially affected agencies

Possible links are rule or model inferences, not confirmed legal obligations.

_The full-text review tagged no state agency. This does not establish that none are affected._

### Types of impact

- Self-funded plan exclusion
- Notice of drug coverage modifications
- Renewal protection for qualifying prescriptions

### People and institutions affected

- Enrollees with qualifying prescription drug coverage
- Health benefit plan issuers
- Group plan sponsors, affected enrollees, and individual plan holders

### Locations

- Texas (statewide): The changes apply statewide to health benefit plans within the scope of the Texas law; no narrower geographic area is specified.

## Links

- Full bill text (official wording, Markdown): https://billatlas.org/live/text/HB1023/I.md
- Official bill history: https://capitol.texas.gov/BillLookup/History.aspx?LegSess=90R&Bill=HB1023
- Official bill text (every version, HTML/PDF/Word): https://capitol.texas.gov/BillLookup/Text.aspx?LegSess=90R&Bill=HB1023
- Open in the tracker: https://billatlas.org/bill/HB1023
- RSS feed of actions: https://billatlas.org/live/feeds/HB1023.xml
- This page as JSON: https://agent.billatlas.org/bills/HB1023.json
- Search all bills: https://agent.billatlas.org/search?q= followed by your words, e.g. https://agent.billatlas.org/search?q=Healthcare

---
Unofficial, independent open-source project; not a state website. The official record and bill text on this page are copied unchanged from the Texas Legislative Council bill files, refreshed hourly, so they can trail the Legislature by up to an hour or two. Computed fields and the AI analysis can be wrong. Not legal advice. For anything that matters, confirm on Texas Legislature Online.
